Navigation Links
Study supports validity of test that indicates widespread unconscious bias
Date:6/17/2009

In the decade since the Implicit Association Test was introduced, its most surprising and controversial finding is its indication that about 70 percent of those who took a version of the test that measures racial attitudes have an unconscious, or implicit, preference for white people compared to blacks. This contrasts with figures generally under 20 percent for self report, or survey, measures of race bias.

A new study published this week validates those findings, showing that the Implicit Association Test, a psychological tool, has validity in predicting behavior and, in particular, that it has significantly greater validity than self-reports in the socially sensitive topics of race, gender, ethnicity, sexual orientation and age.

The research, published in the Journal of Personality and Social Psychology, is an overview and analysis of 122 published and unpublished reports of 184 different research studies. In this analysis, 85 percent of the studies also included self-reporting measures of the type generally used in surveys. This allowed the researchers, headed by University of Washington psychology Professor Anthony Greenwald, to compare the test's success in predicting social behavior and judgment with the success of self-reports.

"In socially sensitive areas, especially black-white interracial behavior, the test had significantly greater predictive value than self-reports. This finding establishes the Implicit Association Test's value in research to understand the roots of race and other discrimination," said Greenwald. "What was especially surprising was how ineffective standard self-report measurers were in the areas in which the test measures have been of greatest interest predicting interracial behavior."

Greenwald created the Implicit Association Test in 1998 and he and Mahzarin Banaji, a Harvard psychology professor, and Brian Nosek, a University of Virginia associate professor of psychology, further developed it. Since th
'/>"/>

Contact: Joel Schwarz
joels@u.washington.edu
206-543-2580
University of Washington
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Study finds reproductive health effects from low doses of bisphenol-A
2. New Study Finds 1 in 4 Multiple Sclerosis Patients With High Out-of-Pocket Costs Not Filling Prescriptions
3. Study Shows Increases in Working After 65 and Using Commercial Insurance
4. Bariatric Advantage High Protein Meal Replacement Clinical Study Presented at European Congress on Obesity
5. AGH Joins Select Group of Medical Centers in Study of Promising New Technology for Treatment of Heart Failure
6. Study Refutes Depression Gene Finding
7. Providing health insurance for US children would be cheaper than expected, study says
8. Study finds autistics better at problem-solving
9. Cannabis alters human DNA -- new study
10. HPV Vaccine Acceptability Study Announces Results
11. MUHC researcher awarded $500,000 to study pathogenesis of infectious disease

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...RSPRING,Md.,Nov.25/PRNewswire-USNewswire/--Anartic...DrugEvaluationandResearch,titled"ADifficultBalance...Nov.26,2009issueofTheNewEnglandJournalofMedicine. ...0090824/FDALOGO ) ,, Inthearticle,Woodcockdiscu...edicationforthosewhoneeditandmanagingtherisksposed...
(Date:11/25/2009)...ANCISCO,Nov.25/PRNewswire/--TheBayAreaAirQualityMa... Spare the Air Alert forThursday,Novem...soranyothersolidfuel,bothindoorsandoutdoors. ,,...litytomorrow,"saidJackBroadbent,executiveofficerof...ctthehealthoftheirneighborsandfellowcommunitymembe...
(Date:11/25/2009)...urvivors of testicular cancer who were treated wit...e effects, including neurological side effects and...ated with chemotherapy, according to a new study p... National Cancer Institute . , Marianne Brydy, M...ersity Hospital, in Bergen, Norway, and colleagues...
(Date:11/25/2009)...ous discovery that grew out of a collaboration bet...ly offer hope to the nearly 10 million Americans w... Also known as hardening of the arteries, periphe...ory problem in which narrowed arteries reduce bloo... red flag for vascular disease, heart attack and s...
(Date:11/25/2009)...low-up period was too short to draw definite concl.... 25 (HealthDay News) -- In diabetic patients with... difference in outcomes at one year whether patien...ting, British researchers report. , Bypass surg...atients with coronary artery disease. However, les...
Breaking Medicine News(10 mins):Health News:Winter Spare the Air Alert in Effect for Thursday, November 26, 2009 2Health News:Engineers, doctors at UCLA develop novel material that could help fight arterial disease 2Health News:Engineers, doctors at UCLA develop novel material that could help fight arterial disease 3Health News:Engineers, doctors at UCLA develop novel material that could help fight arterial disease 4Health News:Stenting May Equal Bypass for Diabetic Heart Patients 2Health News:Stenting May Equal Bypass for Diabetic Heart Patients 3
...ing the chances,of women faced with an aggressive ...nflammatory breast cancer spreads quickly and can ...rodeoxyglucose positron emission,tomography combin...day at the annual meeting of the Radiological Soci...
...rials Worldwide,Inc. announced today that their pe...uit, which is related to Datasci,s U.S. Patent Num...ion of clinical trial data. Under the,terms of the...e granted a license to etrials," said Dr. Marc,Koz...
...VEREST Pivotal Study and Begin ...nue to Build on Initial Data Showing Durability, E...or Percutaneous Repair of Mitr...lves,announced today that it had successfully comp...
...e agency looking into Tamiflu; Relenza also under ...News) -- A U.S. Food and Drug Administration panel...eling for the prescription flu drug Tamiflu (oselt...idering label changes to Tamiflu and another flu d...
...You Measuring the Wrong Things?, NEW YORK and LON... ensure maximum return on investment, sales force ...lobal pharmaceutical industry. Reports,have shown ...address this alarming issue, Eularis announces tod...
..., the leading,provider of databases, software and ...Elan Pharmaceuticals has joined the MetaTox Consor...will be focused on developing,systems biology tool...overy(TM) platform with toxicity ontologies,develo...
Other Medicine News:Health News:PET/CT Brings New Hope to Patients With Deadly Form of Breast Cancer 2Health News:PET/CT Brings New Hope to Patients With Deadly Form of Breast Cancer 3Health News:Evalve(R) Completes $60 Million Series D Financing 2Health News:Evalve(R) Completes $60 Million Series D Financing 3Health News:FDA Mulls Tougher Warning Label on Kids' Flu Drugs 2Health News:FDA Mulls Tougher Warning Label on Kids' Flu Drugs 3Health News:New Report Examines Pharmaceutical Sales Force Effectiveness 2Health News:New Report Examines Pharmaceutical Sales Force Effectiveness 3Health News:Elan Pharmaceuticals Joins GeneGo's MetaTox Consortium 2Health News:Elan Pharmaceuticals Joins GeneGo's MetaTox Consortium 3
(Date:11/24/2009)...ewswire-FirstCall/--Vermillion,Inc.(VRML)(PinkShee...zationandDisclosureStatementtoday,November24,2009,...Delaware.AhearingtoconsiderapprovaloftheDisclosure...hthehearingontheconfirmationofthePlanscheduledforJ...allclaimsinfull.ThePlanisexpected,ifapproved,toall...
(Date:11/24/2009)...wire/--Inadditiontofamily,friendsandhealth,cancers...rThanksgivinggratitudelist. ,, "Theyheardthefac...dofMonday,sverdictstotaling$103millionindamagesaga...000womennationwidewhohavesuedWyethandPfizerpharmac...Prempro.Wisneskiandtheothervictimsofhormonetherapy...
(Date:11/24/2009)...ewswire/--ZargisMedicalCorp.,asubsidiaryofSpeedusC...eResearch(NYSE: SI ),todayannouncedthatitsZargisCa...deofCBS, TheEarlyShow duringasegmentinwhichMarkJan...vewinningproductsfromthepublication,s2009"BestofWh...edtelevisionmorningnewstalkshowbroadcastbyCBSfromN...
Breaking Medicine Technology:Vermillion Files Plan of Reorganization 2Vermillion Files Plan of Reorganization 3Maryland Woman Thankful for Wyeth Verdicts 2Zargis Cardioscan(TM) Featured on The Early Show on CBS 2Zargis Cardioscan(TM) Featured on The Early Show on CBS 31 9 Million Drivers Have Fatigue Related Car Crashes or Near Misses Each Year 60486 11 9 Million Drivers Have Fatigue Related Car Crashes or Near Misses Each Year 60486 21 9 Million Drivers Have Fatigue Related Car Crashes or Near Misses Each Year 60486 31 9 Million Drivers Have Fatigue Related Car Crashes or Near Misses Each Year 60486 4Cell Therapeutics Inc 28CTI 29 to Report Third Quarter Financial Results on November 5 60483 1Lupus Research Institute 3A Benlysta 28TM 29 Trial Results in an Historic Research Breakthrough and Victory for People With Lupus 14678 1Lupus Research Institute 3A Benlysta 28TM 29 Trial Results in an Historic Research Breakthrough and Victory for People With Lupus 14678 2
... EnVivo Pharmaceuticals, Inc.,a privately held bio...egenerative diseases, today announced progress on ...chizophrenia and Huntington,s,diseases. EnVivo Ph...orally,active Alpha 7 Nicotinic Acetylcholine Rece...ts associated with Alzheimer,s disease and,Schizop...
...h Joint Venture Between Bristol-Myers Squibb, Co...n HIV Treatment -, PRINCETON, N.J. and FOSTER CIT...ol-Myers Squibb Company (NYSE: BMY ) and Gilead S...t Health Canada has approved ATRIPLA(R),(efavirenz...fumarate 300,mg) for the treatment of HIV-1 infect...
Other Medicine Technology:EnVivo Pharmaceuticals Announces Progress on Major Drug Programs Focusing on Alzheimer's, Schizophrenia and Huntington's Diseases 2Health Canada Approves ATRIPLA(R) (efavirenz 600 mg/emtricitabine 200 mg/ tenofovir disoproxil fumarate 300 mg), the First Once-Daily Single Tablet Regimen for HIV 2Health Canada Approves ATRIPLA(R) (efavirenz 600 mg/emtricitabine 200 mg/ tenofovir disoproxil fumarate 300 mg), the First Once-Daily Single Tablet Regimen for HIV 3Health Canada Approves ATRIPLA(R) (efavirenz 600 mg/emtricitabine 200 mg/ tenofovir disoproxil fumarate 300 mg), the First Once-Daily Single Tablet Regimen for HIV 4Health Canada Approves ATRIPLA(R) (efavirenz 600 mg/emtricitabine 200 mg/ tenofovir disoproxil fumarate 300 mg), the First Once-Daily Single Tablet Regimen for HIV 5Health Canada Approves ATRIPLA(R) (efavirenz 600 mg/emtricitabine 200 mg/ tenofovir disoproxil fumarate 300 mg), the First Once-Daily Single Tablet Regimen for HIV 6Health Canada Approves ATRIPLA(R) (efavirenz 600 mg/emtricitabine 200 mg/ tenofovir disoproxil fumarate 300 mg), the First Once-Daily Single Tablet Regimen for HIV 7Health Canada Approves ATRIPLA(R) (efavirenz 600 mg/emtricitabine 200 mg/ tenofovir disoproxil fumarate 300 mg), the First Once-Daily Single Tablet Regimen for HIV 8Health Canada Approves ATRIPLA(R) (efavirenz 600 mg/emtricitabine 200 mg/ tenofovir disoproxil fumarate 300 mg), the First Once-Daily Single Tablet Regimen for HIV 9
...ce laboratory and a worldwide leader in innovative...an extensive test menu of highly complex and uniqu.... Owned by the University of Utah, ARUP Laboratori... university teaching hospitals and children's hosp...
...ce laboratory and a worldwide leader in innovative...an extensive test menu of highly complex and uniqu.... Owned by the University of Utah, ARUP Laboratori... university teaching hospitals and children's hosp...
...ce laboratory and a worldwide leader in innovative...an extensive test menu of highly complex and uniqu.... Owned by the University of Utah, ARUP Laboratori... university teaching hospitals and children's hosp...
...ce laboratory and a worldwide leader in innovative...an extensive test menu of highly complex and uniqu.... Owned by the University of Utah, ARUP Laboratori... university teaching hospitals and children's hosp...
Medicine Products: